14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 64 days ( -6.80 % )
Last Price $0.82 0 %
High/ Low $0.82 - $0.82 0%
Chg 7 Days N/A $0.82 $0.82
Chg 30 Days N/A $0.82 $0.82
Chg 12 mos 63.68 % $0.503 $0.82
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -0.460 % Width: 603.92 %
Pred. range - 3 mos $0.82 - $0.82 0 % - 0 %
Pred. range - 12 mos N/A - $3.61 -100.00 % - 339.29 %
Short MA avg 3 mos Sell May 04, 2023 - 58 days
Long MA avg 3 mos Sell Jun 14, 2023 - 30 days
Short/Long MA avg 3 mos Sell Jun 14, 2023 - 30 days
Short MA avg 12 mos Sell May 24, 2023 - 44 days
Long MA avg 12 mos Buy Jun 27, 2023 - 22 days
Short/Long MA avg 12 mos Buy Jun 27, 2023 - 22 days
Pivot Short Sell Jul 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About IMV Inc.

IMV. IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and micr... IMV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT